Table 4 |
||||
|
Adverse events reported in at least 10% of patients in any treatment group. |
||||
|
Abrupt (n = 40) |
Gradual 1 (n = 39) |
Gradual 2 (n = 42) |
All treatments (n = 121) |
|
|
|
||||
|
Patients with any adverse event |
73% |
90 % |
79% |
80% |
|
Insomnia |
23% |
13% |
24% |
20% |
|
Anxiety |
18% |
13% |
14% |
15% |
|
Sedation |
5% |
18% |
12% |
12% |
|
Somnolence |
10% |
10% |
10% |
10% |
|
Headache |
3% |
10% |
7% |
7% |
|
Aggravated psychosis |
13% |
0 |
5 |
6% |
|
|
||||
|
Ganguli et al. BMC Medicine 2008 6:17 doi:10.1186/1741-7015-6-17 |
||||
